L’éjaculation douloureuse

Delavierre, D.; Sibert, L.; Rigaud, J.; Labat, J.-J.

doi:10.1016/j.purol.2013.11.008

Cited by 8 publications

(5 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, it is important to consider that the P is associated with painful ejaculation [25] and therefore, the overall improvement in symptoms could also lead this change. Actually, the main therapeutic option for the treatment of painful ejaculation is represented by alpha-lytic treatment [26]. Finally, the possible increase in serum testosterone levels' (aspect not evaluated in our study) consequence of increased sexual activity [27] or a direct and/or indirect action favored by the administration of Tadalafil [27] could justify the reduced percentage of patients with reduced libido and delayed ejaculation [28] after the treatment.…”

Section: Discussionmentioning

confidence: 91%

Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study

Vignera

Condorelli

Mongioì

et al. 2017

International Journal of Endocrinology

View full text Add to dashboard Cite

Aim of this study was to evaluate the effects of pharmacological treatment with Tadalafil 5 mg daily on symptoms and quality of sperm parameters in selected patients with amicrobic MAGI (male accessory gland inflammation). 120 patients with amicrobic MAGI (mean age 27.0 ± 6.0 years) with mild-moderate ED (erectile dysfunction) according to IIEF-5 (International Index of Erectile Function 5 Items) scores underwent pharmacological treatment with Tadalafil 5 mg daily for six months. Before and after treatment these patients were evaluated through IIEF-5, semen analysis (according to WHO Criteria, 2010), SI-MAGI (Structured Interview about Male Accessory Gland Inflammation), and ultrasound evaluation. Patients with PVE (prostate-vesciculo-epididymitis) showed a significant increase in the percentage of spermatozoa with total (16.0 ± 8.0 versus 30.0 ± 6.0%) and progressive motility (8.00 ± 10.0 versus 25.0 ± 6.00%). It was a significant reduction of the number of patients with complicated ultrasound forms (30.0 versus 52.0) and a significant increase of the number of patients with uncomplicated ultrasound form (90.0 versus 68.0). Finally, there was a significant reduction in the percentage of patients with alterations of sexual function different from DE, such as premature ejaculation (4.00 versus 8.00%), painful ejaculation (4.00 versus 10.0%), delayed ejaculation (12.50 versus 8.00%), and decreased libido (10.0 versus 25.0%).

show abstract

Section: Discussionmentioning

confidence: 91%

Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study

Vignera

Condorelli

Mongioì

et al. 2017

International Journal of Endocrinology

View full text Add to dashboard Cite

show abstract

“…It is associated with prostatitis, ejaculatory duct obstruction, benign prostatic hyperplasia, chronic pelvic pain syndrome, and radical prostatectomy. Treatment options include physical therapy, alpha‐blockers, pudendal nerve blocks and surgical procedures [1, 11]. …”

Section: Discussionmentioning

confidence: 99%

Painful Ejaculation with Cyclobenzaprine: A Case Report and Literature Review

et al. 2015

View full text Add to dashboard Cite

IntroductionSexual dysfunction is a well‐known side effect of antidepressants. Painful ejaculation is a rare side effect that has been reported with the use of some psychiatric drugs such as triclyclic antidepressants. Cyclobenzaprine is a muscle relaxant that is structurally similar to tricyclic antidepressants. It is the most commonly prescribed muscle relaxant in the United States and accounts for 18% of all prescriptions written for chronic back pain.MethodsA 55‐year‐old man was referred to our pain medicine clinic for evaluation and treatment of pain with ejaculation.Main outcome MeasureThe main outcome measure was to review the current published literature and case reports on painful ejaculation from medication use, in particular tricyclic antidepressants.ResultsAfter discontinuation of cyclobenzaprine, our patient's sexual dysfunction resolved. This result was consistent with the literature reviewed on the topic.ConclusionPainful ejaculation is likely an underreported side effect of tricyclic antidepressants and cyclobenzaprine use. Fortunately, these symptoms are reversible and discontinuation of these medications is typically an effective cure. K raus MB , W ie CS , G orlin AW , W isenbaugh ES , and R osenfeld DM . Painful ejaculation with cyclobenzaprine: A case report and literature review. S ex M ed 2015;3:343–345.

show abstract

“…считается, что более длительные курсы лечения (от 12 нед до 6 мес) превосходят короткие курсы по эффективности ликвидации расстройств в виде снМП у пациентов с ХП/сХтБ. согласно данным некоторых исследователей, применение альфа-адреноблокаторов у лиц с сХтБ и сопутствующей ПЭБ дает хорошие терапевтические результаты [58].…”

Section: д и с т а н ц и о н н о е о б у ч е н и еunclassified

Chronic treat pain syndrome

Гурженко

Спиридоненко

2018

View full text Add to dashboard Cite

ГУ «Институт урологии НАмН Украины», г. Киев в статье приведены основные аспекты этиологии, патогенеза, клиники, диагностики и лечения синдрома хронической тазовой боли. Ключевые слова: синдром хронической тазовой боли, альфаадреноблокаторы, хронический простатит.

show abstract

L’éjaculation douloureuse

Cited by 8 publications

References 37 publications

Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study

Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study

Painful Ejaculation with Cyclobenzaprine: A Case Report and Literature Review

Chronic treat pain syndrome

Contact Info

Product

Resources

About